PURPOSE: To identify prognostic indicators in @entity1 treated with radiotherapy (RT) for metastases from @entity157 ( @entity157 ) in abdominal lymph nodes (LNs). @entity1 AND METHODS: RT was used to treat 65  @entity1 for metastases from @entity157 in abdominal LNs. Total radiation dose was 30-60  Gy (median 52.8  Gy), with fraction size 1.8-3  Gy. RT was administered five times per week to an equivalent dose in 2-Gy fractions (EQD2; Gy10) of 32.5-65  Gy10 (median 54  Gy10) and an a/bratio for @entity5 and acute effects of normal tissue of  10. RESULTS: Median @entity1349 ( @entity1349 ) in all @entity1 was 8.1  months. LN responders had significantly higher median @entity1349 than nonresponders (14.5  vs. 3.7  months, p   <   0.05). Multivariate analysis showed that @entity1 -Pugh classification, status of @entity5 , number of metastatic LNs, and LN response were independently predictive of @entity1349 (p   <   0.05 each). Based on results of multivariate analysis, @entity1 were prognostically stratified according to pretreatment risk factors, including @entity1 -Pugh classification, @entity5 status, and number of metastatic LNs; with the expected median @entity1349 in @entity1 with >=    2,  1, and 0  risk factors being 2.9,  9.8, and 27.6  months, respectively (p   <   0.05). CONCLUSION: Our data showed that LN response to RT was an independent prognostic factor for @entity1349 in advanced @entity157 @entity1 with abdominal LN metastases, and suggested that RT for metastatic LNs might improve @entity1349 in these @entity1 . In addition, our data suggest that @entity1 -Pugh classification, @entity5 status, and number of metastatic LNs may be useful prognostic and therapeutic indicators for selecting treatment strategies.

Prognostic indicators for radiotherapy of abdominal lymph node metastases from XXXX .

@entity1 :: ('9606', 'Species') :: ['Child', 'patients', 'PATIENTS'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'intrahepatic tumor'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
